NAPEPLD
Basic information
Region (hg38): 7:103099776-103149560
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NAPEPLD gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 27 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 1 | 2 |
Variants in NAPEPLD
This is a list of pathogenic ClinVar variants found in the NAPEPLD region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-103103443-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
7-103103467-C-T | not specified | Uncertain significance (Aug 04, 2021) | ||
7-103103494-C-G | not specified | Uncertain significance (Oct 06, 2021) | ||
7-103115100-G-A | not specified | Uncertain significance (May 25, 2022) | ||
7-103115123-G-C | not specified | Uncertain significance (Sep 27, 2022) | ||
7-103115174-C-G | not specified | Uncertain significance (Mar 01, 2023) | ||
7-103119619-G-C | not specified | Uncertain significance (Jul 09, 2021) | ||
7-103119622-C-G | not specified | Uncertain significance (Dec 07, 2021) | ||
7-103119674-C-T | not specified | Uncertain significance (Jan 12, 2024) | ||
7-103119704-C-T | not specified | Uncertain significance (Feb 22, 2023) | ||
7-103119720-T-C | Benign (May 09, 2018) | |||
7-103119754-C-A | not specified | Uncertain significance (Jan 02, 2024) | ||
7-103119815-C-T | not specified | Uncertain significance (Dec 16, 2021) | ||
7-103119863-T-C | not specified | Uncertain significance (Dec 11, 2023) | ||
7-103119880-A-G | not specified | Uncertain significance (Apr 24, 2023) | ||
7-103119937-T-C | not specified | Uncertain significance (Oct 02, 2023) | ||
7-103119955-T-C | not specified | Uncertain significance (Nov 27, 2023) | ||
7-103120104-T-G | not specified | Uncertain significance (Nov 23, 2021) | ||
7-103120111-A-G | not specified | Uncertain significance (Jan 25, 2023) | ||
7-103120117-G-A | not specified | Uncertain significance (May 25, 2022) | ||
7-103120152-T-G | not specified | Uncertain significance (Nov 30, 2022) | ||
7-103120175-G-A | not specified | Uncertain significance (Oct 10, 2023) | ||
7-103128493-C-G | not specified | Uncertain significance (Dec 08, 2023) | ||
7-103128574-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
7-103128629-G-A | Benign (May 09, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NAPEPLD | protein_coding | protein_coding | ENST00000417955 | 4 | 49785 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000294 | 0.939 | 125704 | 0 | 42 | 125746 | 0.000167 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.312 | 203 | 216 | 0.940 | 0.0000114 | 2620 |
Missense in Polyphen | 56 | 64.607 | 0.86677 | 735 | ||
Synonymous | 0.359 | 72 | 76.0 | 0.948 | 0.00000426 | 722 |
Loss of Function | 1.73 | 10 | 17.9 | 0.558 | 0.00000100 | 192 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000264 | 0.000264 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000221 | 0.000220 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000655 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolyzes N-acyl-phosphatidylethanolamines (NAPEs) to produce N-acylethanolamines (NAEs) and phosphatidic acid (PubMed:25684574, PubMed:14634025, PubMed:16527816). Responsible for the generation of these bioactive fatty acid ethanolamides (FAEs), including anandamide (N-arachidonoylethanolamine), the ligand of cannabinoid and vanilloid receptors (PubMed:14634025). As a regulator of lipid metabolism in the adipose tissue, mediates the crosstalk between adipocytes, gut microbiota and immune cells to control body temperature and weight. In particular, regulates energy homeostasis by promoting cold-induced brown or beige adipocyte differentiation program to generate heat from fatty acids and glucose (By similarity). {ECO:0000250|UniProtKB:Q8BH82, ECO:0000269|PubMed:14634025, ECO:0000269|PubMed:16527816, ECO:0000269|PubMed:25684574}.;
- Pathway
- Retrograde endocannabinoid signaling - Homo sapiens (human);Cannabinoid receptor signaling;Signaling by GPCR;Disease;Signal Transduction;The canonical retinoid cycle in rods (twilight vision);Biosynthesis of A2E, implicated in retinal degradation;G alpha (i) signalling events;Retinoid cycle disease events;Diseases associated with visual transduction;Visual phototransduction;GPCR downstream signalling;Diseases of signal transduction
(Consensus)
Recessive Scores
- pRec
- 0.185
Intolerance Scores
- loftool
- 0.474
- rvis_EVS
- 0
- rvis_percentile_EVS
- 53.73
Haploinsufficiency Scores
- pHI
- 0.157
- hipred
- N
- hipred_score
- 0.378
- ghis
- 0.582
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.230
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Napepld
- Phenotype
- homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- retinoid metabolic process;temperature homeostasis;aging;phospholipid catabolic process;response to isolation stress;host-mediated regulation of intestinal microbiota composition;positive regulation of inflammatory response;N-acylethanolamine metabolic process;N-acylphosphatidylethanolamine metabolic process;positive regulation of brown fat cell differentiation;negative regulation of eating behavior
- Cellular component
- Golgi membrane;nuclear envelope;nucleoplasm;early endosome;Golgi apparatus;cytosol;early endosome membrane;photoreceptor outer segment membrane;membrane-bounded organelle;extracellular exosome
- Molecular function
- zinc ion binding;identical protein binding;N-acylphosphatidylethanolamine-specific phospholipase D activity;N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity